Webcast Advisory - NUCRYST Pharmaceuticals Webcast of Conference Call to Discuss 2007 Fourth Quarter Results

WAKEFIELD, MA, Feb. 13 /PRNewswire-FirstCall/ - NUCRYST PharmaceuticalsCorp. will hold a webcast at 5:00 p.m. EST on Thursday, February 14, 2008regarding the company's 2007 fourth quarter results.

In addition to standard disclosure over wire services, a news release andfinancial statements will be posted on the NUCRYST web site. To listen to thecall live on the Internet, please go to www.nucryst.com.

Thomas E. Gardner, Chairman, President, & CEO and Eliot M. Lurier, VicePresident, Finance & Administration, and CFO will participate on the call.

An audio file of the call will be archived and posted on the NUCRYST website.

NUCRYST Pharmaceuticals (NASDAQ: NCST; TSX: NCS) develops, manufacturesand commercializes medical products that fight infection and inflammationusing its patented atomically disordered nanocrystalline silver technology.Smith & Nephew plc sell a range of advanced wound care products under theirActicoat(TM) trade mark: Acticoat(TM) products incorporate NUCRYST'sSILCRYST(TM) coatings and are sold in over 30 countries. NUCRYST is alsodeveloping pharmaceutical products to address medical conditions that arecharacterized by both infection and inflammation. The company has developedits proprietary nanocrystalline silver in a powder form, referred to as NPI32101 for use in medical devices and as an active pharmaceutical ingredient.

SOURCE NUCRYST Pharmaceuticals Corp.

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...